- Home
- ALV vs AXSM Comparison
ALV vs AXSM Comparison
Compare ALV & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALV | AXSM |
|---|---|---|
| Founded | 1953 | 2012 |
| Country | Sweden | United States |
| Employees | 65200 | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 9.0B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | ALV | AXSM |
|---|---|---|
| Price | $102.89 | $156.19 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 17 |
| Target Price | $137.10 | ★ $209.18 |
| AVG Volume (30 Days) | ★ 617.6K | 493.1K |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | ★ 3.35% | N/A |
| EPS Growth | N/A | ★ 38.56 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2.76 | $58.34 |
| Revenue Next Year | $3.52 | $54.30 |
| P/E Ratio | $13.10 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $75.49 | $86.99 |
| 52 Week High | $130.14 | $191.50 |
Technical Indicators
Market Signals| Indicator | ALV | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 18.25 | 31.90 |
| Support Level | N/A | $148.14 |
| Resistance Level | $128.33 | $191.13 |
| Average True Range (ATR) | 2.69 | 4.67 |
| MACD | -1.43 | -1.37 |
| Stochastic Oscillator | 2.05 | 9.19 |
Price Performance
Historical ComparisonAbout ALV Autoliv Inc.
Autoliv Inc is a developer, manufacturer, and supplier of passive safety systems to the automotive industry with a broad range of product offerings. Its product portfolio includes passive safety systems for commercial vehicles, battery cut-off switches, safety solutions for riders of motorcycles and bikes, airbags (including steering wheels and inflators), seatbelts, etc. Geographically, the group operates in the Americas, Europe, China, and Asia, excluding China, of which the maximum revenue is generated from its business in the Americas.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.